Skip to main content
. 2020 Jan 8;156(3):303–311. doi: 10.1001/jamadermatol.2019.4315

Table 3. Sensitivity Analyses of Podophyllotoxin Use During Pregnancy and Risk of Spontaneous and Induced Abortion.

Sensitivity Analyses No. With Outcome/Total No. (%) Hazard Ratio (95% CI)
Spontaneous abortion
Compared with podophyllotoxin use in past 2 y before pregnancy only, matched in a 1:2 ratio
Podophyllotoxin exposure in pregnancy 141/1690 (8.3) 0.89 (0.73-1.09)
Podophyllotoxin use 2 y before pregnancy onlya 318/3380 (9.4) 1 [Reference]
Podophyllotoxin exposure during gestational days 0-154
Exposed 108/1325 (8.2) 0.89 (0.73-1.09)
Unexposed 1227/13 250 (9.3) 1 [Reference]
Induced abortion
Induced abortions overall
Exposed 587/1690 (34.7) 1.15 (1.05-1.25)
Unexposed 5081/16 900 (30.1) 1 [Reference]
Post hoc analyses
Induced abortions before end of gestational wk 12 (wk 6-12)
Exposed 567/1690 (33.6) 1.15 (1.06-1.26)
Unexposed 4870/16 900 (28.8) 1 [Reference]
Induced abortions later than gestational wk 12 (wk 13-22)
Exposed 20/1690 (1.2) 1.01 (0.64-1.60)
Unexposed 211/16 900 (1.3) 1 [Reference]
Birth defects among induced abortions in a subcohort, 2004-2016
Exposed 2/1238 (0.2) 0.65 (0.15-2.72)
Unexposed 28/11 239 (0.3) 1 [Reference]
a

Women with filled prescriptions for local podophyllotoxin in the period from 2 years until 3 months before pregnancy but with no filled prescriptions during the 3 months before pregnancy or in pregnancy.